AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2005
Mar 9, 2005
30339_dirs_2005-03-09_350a2863-07b2-457a-8edf-545ce1bdb66c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-03-07
Reporting Person: HUGILL HERBERT L (Pres.of the Americas, Pharma.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-03-07 | Common stocks | A | 3365 | — | Acquired | 22745.0438 | Direct |
| 2005-03-07 | Common stocks | A | 1447.69 | $25.5700 | Acquired | 6294.5333 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-03-07 | Stock Option (Right to Buy) | $25.5300 | A | 13000 | Acquired | 2015-03-09 | Common Stock (13000.00) | Direct |
Footnotes
F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
F2: Bonus and incentive shares granted on 3/7/05.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12